Bill
S 268
Requires state Medicaid to cover implantable infusion pumps for chronic non-cancer pain as standard benefits, expanding access for eligible patients and providers.
Title: Includes implantable infusion pumps for chronic non-cancer pain management as standard coverage for medical assistance
Status: Referred to Health (Introduced January 28, 2025)
Note on source materials
- The materials you provided contain multiple, unrelated documents (a New Jersey homelessness/eviction-prevention substitute, a Massachusetts bill on real‑estate dual agency, and inconsistent legislative action/sponsor lists). None of those documents contain the full text of a bill that matches the title above.
- The summary below is based on the bill title and available bill metadata (bill number, title, status, and introduction date). I flag where specific provisions are not in the record you supplied and recommend obtaining the bill text for exact language.
Bill at a glance
- Purpose: To require that implantable infusion pumps used for chronic non‑cancer pain management be treated as standard, covered benefits under the state’s medical assistance program (i.e., Medicaid/state Medicaid-like coverage).
- Effect: Expands the set of durable medical devices/therapies that must be covered for eligible medical assistance recipients to include implantable infusion pumps for long‑term pain management.
Likely key provisions (inferred from title — confirm with bill text)
- Coverage mandate: State medical assistance would be required to cover implantable infusion pumps (including device, implantation procedure, programming, maintenance, and medically necessary refills of infusion medication) for beneficiaries who meet clinical eligibility.
- Medical necessity criteria: The bill likely directs the Medicaid program to adopt clinical criteria and prior‑authorization policies to determine which beneficiaries qualify (e.g., diagnosis of chronic non‑cancer pain, prior trials of conservative therapies, specialist recommendation).
- Provider and supplier rules: May set requirements for qualified prescribers/implanting physicians and durable medical equipment suppliers.
- Reimbursement: Could require establishment or adjustment of payment rates for device implantation, device supply, ongoing programming, nursing or outpatient services, and physician follow‑up.
- Fraud/abuse safeguards: May include measures for utilization review, tapers, periodic reassessments, and limits to address inappropriate use or diversion.
Who would be affected
- Medical assistance (Medicaid) beneficiaries with chronic non‑cancer pain who might be candidates for infusion pump therapy.
- Providers: pain specialists, surgeons, hospitals, DME suppliers, home health agencies.
- State Medicaid program: administrative and fiscal implications for benefits, utilization controls, and reimbursement.
- Potential indirect effects on private insurers if the policy influences standard of care.
Implementation and timeline
- Current status: Referred to the Health committee (as of Jan 28, 2025). No enactment date supplied.
- Usual next steps: Committee hearings, fiscal analysis, possible amendments, votes in chamber(s), and (if enacted) an effective date specified in the bill.
Potential fiscal and policy considerations
- Fiscal impact: Implantable pumps and associated ongoing medication and services carry substantial upfront and recurring costs; coverage expansion could increase Medicaid spending while potentially reducing other costs (e.g., emergency care) if pain is better controlled.
- Clinical outcomes: For selected patients, pump therapy can improve pain control and function; appropriate patient selection and monitoring are critical.
- Access equity: May improve access to advanced pain therapies for low‑income beneficiaries who previously could not afford them.
- Oversight needs: Strong medical‑necessity criteria, prior authorization, and monitoring recommended to avoid overuse or inappropriate prescribing of opioids/other controlled substances.
Recommended next steps
1. Obtain and review the full bill text and any committee analyses to confirm scope, definitions, eligibility criteria, reimbursement rules, and effective date.
2. Seek the fiscal note from the state Medicaid agency to quantify projected costs and offsets.
3. Review related regulations and existing medical assistance benefits for durable medical equipment and pain management to identify implementation gaps.
If you can provide the bill text or a link to it, I will produce a detailed, line‑by‑line summary of provisions and impacts.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
